CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Cellfood

CellfoodThe CELLFOOD product was introduced in 1978 and has a long history of beneficial use by many doctors, research centers, health clinics and consumers with many reports of exceptional results.

CELLFOOD is the world's leading high-performance oxygen and hydrogen based consumer health product. For over 40 years, CELLFOOD has safely provided nutritional benefits, without toxicity.

"As you begin to introduce more pure oxygen into your system, it's only a matter of time before your body will begin to respond with new levels of vitality, energy, endurance, and most of all wellbeing." Michelle Schoffro Cook, DNM, DAC, CNC,CITP

All elements of Cellfood are natural substances. Cellfood has no alcohol, no glucose, and no ingredients that are on the list of ban substances regarding international professional and amateur athletic associations. The nutrients in Cellfood are both ionic and colloidal in form. They take on a negative (ionic charge) and remain suspended in liquid. Because most body fluids are colloidal and negatively charged, the body perceives Cellfood as normal healthy body fluid and allows the nutrients to pass immediately through membranes of mouth, throat and esophagus directly into the bloodstream.

Invented by Everett L. Story CELLFOOD is a proprietary formulation of a super energized colloidal mineral concentrate. CELLFOOD's Di-base, Di-pole Deuterium Sulfate provides an incredible oxygen source and delivery system to the body at the cellular level. Scientists recognize that most diseases and infections are caused by oxygen starvation at the cellular level. This award winning formula naturally provides the highest level of nascent oxygen and hydrogen in supplement form improving energy, endurance, and natural health.

CELLFOOD has the unique ability to dissociate the water molecule into nascent hydrogen and nascent oxygen. This water "splitting" technology enables the release of hydrogen and oxygen gases simultaneously in a chain reaction that involves one five-hundred thousandths of the available moisture at one time. Water "splitting" is achieved by means of shifting and weakening the bonding electrons (ionic transfers) of the water molecule towards oxygen and away from hydrogen. CELLFOOD allows the bonds in the electron distribution to be unsymmetrical (polar). The water molecule can then be described as Di-pole, with the oxygen atom acting as a negative pole and the hydrogen acting as a positive pole.

Every product manufactured by Nu Science Corporation / Deutrel Industries contains CELLFOOD and is made from the finest natural substances. These substances are cryogenically extracted (extreme cold), not chemically extracted, and are totally non-toxic. All products have been thoroughly tested and DO NOT contain any substance that is on the "banned list of substances" regarding International, Professional, and Amateur Athletic Associations or competitions. Product research and testing information has been completed and compiled by this research facility as well as several independent testing laboratories and clinics

Cellfood generates oxygen and hydrogen over a period of time, making it the most effective oxygen therapy known today.

Cellfood also contains, 78 super energized (ionic form) minerals, 34 enzymes, 17 amino acids and electrolytes. Making Cellfood the most complete nutritional supplement.

Minerals are needed for the proper composition of the body fluids, the formation of blood and bone, the maintenance of healthy nerve function, and the regulation of muscle tone. Very few people realize that vitamins cannot function without the aid of minerals. Processed or refined foods (for example, white flour and white sugar) are almost devoid of all trace minerals. Lack of a single mineral can cause mental and physical problems.  

Enzymes are complex proteins necessary for the digestion of food. They release valuable vitamins, minerals and amino acids which keep us alive and healthy.  Each enzyme acts upon a specific food; one cannot substitute for the other. A shortage or deficiency, or even the absence of one single enzyme, can make all the difference between health and sickness. Enzymes are very susceptible to heat and are destroyed in processing. 

Amino acids are the "building Blocks" of the body. Besides building cells and repairing tissue, they form antibodies to combat invading bacteria & viruses; they are part of the enzyme & hormonal system; they build nucleoproteins (RNA & DNA); they carry oxygen throughout the body and participate in muscle activity. When protein is broken down by digestion the result is 22 known amino acids. Eight are essential (cannot be manufactured by the body) the rest are non-essential (can be manufactured by the body with proper nutrition).

Cellfood aids in:  
Digestive Process
Often stops cold or flu if applied at first signs
Cleansing of Upper and Lower Intestines
Delivery of 78 assimilable elements to each cell
Provides steady flow of oxygen and hydrogen to all of body
Rehydrate fliers (jet lag)
Protects from picking up nuclear fallout by providing minerals that vibrate near the frequencies of isotopes
Will purify standard tap water
Causes clotted blood to unclot
Helps relax if wired and get going if tired
Increases brain function significantly
Reverse severe dehydration
Often stops cold or flue if applied at first signs
Cleans colon while elimination overgrowth of undesirable microorganisms
Boosts immune system

  • Cellfood™ Improves Respiratory Metabolism of Endothelial Cells and Inhibits Hypoxia-Induced Reactive Oxygen Species (Ros) Generation ?

    Abstract Title:

    Cellfood™ Improves Respiratory Metabolism of Endothelial Cells and Inhibits Hypoxia-Induced Reactive Oxygen Species (Ros) Generation

    Abstract Source:

    https://pubmed.ncbi.nlm.nih.gov/21893688/?from_term=cellfood&from_pos=6

    Abstract Author(s):

    Ferrero E, Fulgenzi A, Belloni D, Foglieni C, Ferrero ME.

    Abstract:

    Endothelial mitochondria, the major site of ATP generation, modulate the intracellular dynamics of reactive oxygen species (ROS), which, in turn, control endothelial function. Adequate oxygen (O(2)) supply is required by endothelial cells (EC). Both hypoxia and hyperoxia may favor the overproduction of ROS leading to oxidative stress, mitochondrial damage and endothelial dysfunction. We investigated the capability and mechanisms of Cellfood™ (CF), an antioxidant compound, to modulate O(2) availability and mitochondrial respiratory metabolism and to regulate ROS generated by hypoxia in EC in vitro. Human umbilical vein endothelial cells (HUVEC) and ECV-304 were evaluated for the O(2) consumption using a Clark's electrode. The O(2) consumption rate rose, during the first minutes after CF addition and was associated with increase in mitochondrial oxidative capacity and good cell viability. Similar behaviours were observed when EC were exposed to CF for up to 8 days. The O(2) consumption increased and was accompanied by both intracellular rise of ATP and maintainment of LDH concentration. Hypoxia-induced ROS generation was significantly inhibited by CF, through the up-regulated expression of MnSOD, an anti-oxidant responsible for mitochondrial function preservation. The EC hypoxic response is mediated by the hypoxia master regulator HIF-1alpha whose activation was attenuated by CF, in concomitance with MnSOD up-regulation. Our results suggest a role for CF in improoving respiratory metabolism and in activating anti-oxidant mechanisms in EC, thus preserving endothelial function.

    Article Published Date : Jun 03, 2011

  • Improvement of Oxidative and Metabolic Parameters by Cellfood Administration in Patients Affected by Neurodegenerative Diseases on Chelation Treatment ?

    Abstract Title:

    Improvement of Oxidative and Metabolic Parameters by Cellfood Administration in Patients Affected by Neurodegenerative Diseases on Chelation Treatment

    Abstract Source:

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119708/

    Abstract Author(s):

    Fulgenzi A, De Giuseppe R, Bamonti F, Ferrero ME.

    Abstract:

    Objective: This prospective pilot study aimed at evaluating the effects of therapy with antioxidant compounds (Cellfood, and other antioxidants) on patients affected by neurodegenerative diseases (ND), who displayed toxic metal burden and were subjected to chelation treatment with the chelating agent calcium disodium ethylenediaminetetraacetic acid (CaNa2EDTA or EDTA).

    Methods: Two groups of subjects were studied: (a) 39 patients affected by ND and (b) 11 subjects unaffected by ND (controls). The following blood parameters were analyzed before and after three months' treatment with chelation+Cellfood or chelation+other antioxidants: oxidative status (reactive oxygen species, ROS; total antioxidant capacity, TAC; oxidized LDL, oxLDL; glutathione), homocysteine, vitamin B12, and folate.

    Results: After 3-months' chelation+Cellfood administration oxLDL decreased, ROS levels were significantly lower, and TAC and glutathione levels were significantly higher than after chelation+other antioxidants treatment, both in ND patients and in controls. Moreover, homocysteine metabolism had also improved in both groups.

    Conclusions: Chelation+Cellfood treatment was more efficient than chelation+other antioxidants improving oxidative status and homocysteine metabolism significantly in ND patients and controls. Although limited to a small number of cases, this study showed how helpful antioxidant treatment with Cellfood was in improving the subjects' metabolic conditions.

    Article Published Date : Jul 10, 2014

  • Metabolism Modifications and Apoptosis Induction After Cellfood™ Administration to Leukemia Cell Lines ?

    Abstract Title:

    Metabolism Modifications and Apoptosis Induction After Cellfood™ Administration to Leukemia Cell Lines

    Abstract Source:

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847119/

    Abstract Author(s):

    Catalani S, Carbonaro V, Palma F, Arshakyan M, Galati R, Nuvoli B, Battistelli S, Canestrari F, Benedetti S.

    Abstract:

    Background

    Cellfood™ (CF) is a nutritional supplement containing deuterium sulphate, minerals, amino acids, and enzymes, with well documented antioxidant properties. Its organic and inorganic components are extracted from the red algae Lithothamnion calcareum, whose mineral extract has shown growth-inhibitory effect both on in vitro and in vivo models. The purpose of this study was to evaluate the antiproliferative effects of CF on leukemic cells. In fact, according to its capacity to modulate O2 availability and to improve mitochondrial respiratory metabolism, we wondered if CF could affect cancer cell metabolism making cells susceptible to apoptosis.

    Methods

    Three leukemic cell lines, Jurkat, U937, and K562, were treated with CF 5 μl/ml up to 72 hours. Cell viability, apoptosis (i.e. caspase-3 activity and DNA fragmentation), hypoxia inducible factor 1 alpha (HIF-1α) concentration, glucose transporter 1 (GLUT-1) expression, lactate dehydrogenase (LDH) activity and lactate release in the culture medium were detected and compared with untreated cells.

    Results

    CF significantly inhibited leukemic cell viability by promoting cell apoptosis, as revealed by caspase-3 activation and DNA laddering. In particular, CF treated cells showed lower HIF-1α levels and lower GLUT-1 expression as compared to untreated cells. At the same time, CF was able to reduce LDH activity and, consequently, the amount of lactate released in the extracellular environment.

    Conclusions

    We supplied evidence for an antiproliferative effect of CF on leukemia cell lines by inducing cell death through an apoptotic mechanism and by altering cancer cell metabolism through HIF-1α and GLUT-1 regulation. Thanks to its antioxidative and proapoptotic properties, CF might be a good candidate for cancer prevention.

    Article Published Date : Set 09, 2013

  • The Antioxidant Protection of CELLFOOD Against Oxidative Damage in Vitro

    Abstract Title:

    The Antioxidant Protection of CELLFOOD Against Oxidative Damage in Vitro

    Abstract Source:

    https://doi.org/10.1016/j.fct.2011.06.029

    Abstract Author(s):

    SerenaBenedetti,SimonaCatalani,FrancescoPalma,FrancoCanestrari

    Abstract:

    CELLFOOD® (CF) is an innovative nutritional supplement containing 78 ionic/colloidal trace elements and minerals combined with 34 enzymes and 17 amino acids, all suspended in a solution of deuterium sulfate. The aim of this study was to investigate, for the first time, the antioxidant properties of CF in vitro in different model systems.

    Three pathophysiologically relevant oxidants were chosen to evaluate CF protection against oxidative stress: hydrogen peroxide, peroxyl radicals, and hypochlorous acid. Both biomolecules (GSH and plasmid DNA) and circulating cells (erythrocytes and lymphocytes) were used as targets of oxidation.

    CF protected, in a dose-dependent manner, both GSH and DNA from oxidation by preserving reduced GSH thiol groups and supercoiled DNA integrity, respectively. At the same time, CF protected erythrocytes from oxidative damage by reducing cell lysis and GSH intracellular depletion after exposure to the oxidant agents. In lymphocytes, CF reduced the intracellular oxidative stress induced by the three oxidants in a dose-dependent manner.

    The overall in vitro protection of biomolecules and cells against free radical attacks suggests that CF might be a valuable coadjuvant in the prevention and treatment of various physiological and pathological conditions related to oxidative stress, from aging to atherosclerosis, from neurodegeneration to cancer.

    Highlights

    ► CELLFOOD® is a novel nutritional supplement based on a solution of deuterium sulfate, enzymes, amino acids, and minerals. ► The efficacy of CF has been evidenced in fibromyalgic subjects and athletes, possibly due to an antioxidant protection. ► In this study we investigate for the first time the antioxidant properties of CF in vitro in different model systems. ► CF protects both biomolecules (GSH and DNA) and cells (erythrocytes and lymphocytes) from oxidation. ► CF may be a valuable coadjuvant in the prevention and treatment of various conditions related to oxidative stress.

    Article Published Date : Set 09, 2011

  • The Effect of CELLFOOD TM on Radiotherapy or Combined Chemoradiotherapy: Preclinical Evidence ?

    Abstract Title:

    The Effect of CELLFOOD TM on Radiotherapy or Combined Chemoradiotherapy: Preclinical Evidence

    Abstract Source:

    https://pubmed.ncbi.nlm.nih.gov/31662796/?from_term=cellfood&from_pos=4

    Abstract Author(s):

    Nuvoli B, Amadio B, Cortese G, Benedetti S, Antoniani B, Soriani A, Carosi M, Strigari L, Galati R.

    Abstract:

    Background: Based on previous observations that the nutraceutical CELLFOOD™ (CF), the 'physiological modulator' that aimed to make oxygen available 'on demand', inhibits the growth of cancer cells, this study was designed to investigate the role of CF in the regulation of hypoxia-inducible factor 1 alpha (HIF1α) and its correlated proteins, phosphoglycerate kinase 1 and vascular endothelial growth factor. Our idea was that CF, acting on HIF1α, in combination with current anticancer therapies could improve their effectiveness.

    Methods: To evaluate the effect of CF in association with radiotherapy and chemotherapy, different human cancer cell lines and mice with mesothelioma were analysed by tumour growth, clonogenic assay, western blot and immunohistochemical analysis.

    Results: CF in combination with radiation with or without cisplatin increases the death rate of cancer cells. In vivo, 70% of mice treated with CF before the mesothelioma graft did not show any tumour growth, indicating a possible preventive effect of CF. Moreover, in mouse mesothelioma xenografts, CF improves the effect of radiotherapy also in combination with chemotherapy treatment. Immunohistochemical analysis of tumour explants showed that HIF1α expression was reduced by the combination of CF and radiotherapy treatment and even more by the combination of CF and radiotherapy and chemotherapy treatment. Mechanistically, CF increases the fraction of oxygenated cells, making the radiotherapy more effective with a greater production of reactive oxygen species (ROS) that in turn, reduce the HIF1α expression. This effect is amplified by further increase in ROS from chemotherapy.

    Conclusions: Collectively, results from preclinical trials suggest that CF could be a useful intervention to improve the efficacy of radiotherapy or combined treatment strategies and could be a promising treatment modality to counteract cancer.

    Article Published Date : Oct 13, 2019

  • Cellfood

    facebook Share on Facebook

    CellfoodThe CELLFOOD product was introduced in 1978 and has a long history of beneficial use by many doctors, research centers, health clinics and consumers with many reports of exceptional results.

    CELLFOOD is the world's leading high-performance oxygen and hydrogen based consumer health product. For over 40 years, CELLFOOD has safely provided nutritional benefits, without toxicity.

    "As you begin to introduce more pure oxygen into your system, it's only a matter of time before your body will begin to respond with new levels of vitality, energy, endurance, and most of all wellbeing." Michelle Schoffro Cook, DNM, DAC, CNC,CITP

  • Cellfood

  • CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways ?

    Abstract Title:

    CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways

    Abstract Source:

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975718/

    Abstract Author(s):

    Nuvoli B, Santoro R, Catalani S, Battistelli S, Benedetti S, Canestrari F, Galati R.

    Abstract:

    Background: CELLFOOD™ (CF) is a nutraceutical non-addictive, non-invasive, and completely non-toxic unique proprietary colloidal-ionic formula. Little is known about its effect on cancer cells in solid tumors. The aim of this study was to evaluate the effect that CF has on different cancer cell lines and the mechanism by which the nutraceutical works.

    Methods: The effect of CF on HFF (normal fibroblasts), Met5A (mesothelium), MSTO-211H, NCI-2452, Ist-Mes1, MPP89, Ist-Mes2 (mesothelioma), M14 (melanoma), H1650, H1975 (lung cancer), SKRB3 (breast cancer), and HCT-116 (colorectal cancer) cell growth was tested by cell proliferation and clonogenic assay. Among all of them, MSTO-211 and HCT-116 were analyzed for cell cycle by flow cytometry and western blot.

    Results: All human cancer lines were suppressed on cell growth upon 1:200 CF treatment for 24 and 48 hours. Death was not observed in HFF and Met5A cell lines. Cell cycle analysis showed an increased sub-G1 with reduction of G1 in MSTO-211 and a cell cycle arrest of in G1 in HCT116. Activation of caspase-3 and cleavage of PARP confirmed an apoptotic death for both cell lines. Increased expression levels of p53, p21, and p27, downregulation of c-myc and Bcl-2, and inhibition of Akt activation were also found in CF-treated MSTO-211 and HCT-116 cells.

    Conclusions: These findings ascertained an interaction between p53, c-myc, p21, p27, Bcl-2, PI3K/Akt pathway, and CF-induced apoptosis in MSTO-211H and HCT-116 cells, suggesting that CF acts as an important regulator of cell growth in human cancer cell lines. CF could be a useful nutraceutical intervention for prevention in colon cancer and mesothelioma.

    Article Published Date : Mar 05, 2014

  • Efficacy of Cellfood's therapy (deutrosulfazyme) in fibromyalgia📎

    Abstract Title:

    [Efficacy of Cellfood's therapy (deutrosulfazyme) in fibromyalgia].

    Abstract Source:

    Reumatismo. 2007 Oct-Dec;59(4):316-21. PMID: 18157288

    Abstract Author(s):

    M E Nieddu, L Menza, F Baldi, B Frediani, R Marcolongo

    Abstract:

    OBJECTIVE: To assess the efficacy of Cellfood's therapy in the treatment of fibromyalgia. METHODS: This study was a single-blind, cross-over, randomized placebo-controlled trial. Forty female were selected from 320 cases investigated in the period 2003-2005 of June. To be included in this study, it was required that the diagnosis of fibromyalgia was made by a specialist in according to the ACR classification criteria of 1990. The patient's age was between 35-47 years, the choice of criteria were the absence of improvements with the conventional therapy and the normality of medical check-up. The patients were divided into two different-groups of thirty-one and nine subjects, each-one (group A) treated with Cellfood for six months in according to the Eurodream's scheme, and each-other (group B) treated with placebo for three months and successively with Cellfood for three months. Besides we have estimated the tender points with algometer and the health status of women with the Fibromyalgia Impact Questionnaire (FIQ) at the baseline (T0) and at three (T1) and six month (T2). RESULT: The group A had an appreciable improvement of the parameters at T1 statistically significant compared to the group B, while we observed a stability of they at T2 on the group A and an improvement of the parameters of the group B statistically non significant compared to each-one. CONCLUSION: Our result suggest that the Cellfood's therapy improve fibromyalgia symptoms and health-related quality of life.

    Article Published Date : Oct 01, 2007

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.

Ok Decline
More information